Genzyme Corp.’s chief executive officer, Henri A. Termeer , will leave his post of 26 years after Sanofi-Aventis SA closes its $20.1 billion purchase of his company. He may not be out of a job for long.
"Fiat Chrysler is neither attractive nor rich enough to attract anyone better than a desperate castoff."
- Erik Gordon on Jan 05, 2015
Taking Stock: M&A Monday With Erik Gordon
Taking Stock: Chart Of The Day, Emerging Markets
Bloomberg Law Brief: Suit Over Knicks Game Ejection (Audio)
Bloomberg Law: Lawsuit Over Knicks Game Ejection (Audio)
Michigan’s Gordon, Bloomberg’s McCracken on Merck Deal (Audio)